Psychiatric Drug Facts with Dr. Peter Breggin - The Big Suicide Loophole The Big Suicide Loophole in Antidepressant Drug Safety Studies By Peter R. Breggin, M.D.

http://breggin.com/index.php?option=com_content&task=view&id=117

Most important, two in-house memoranda show that Eli Lilly was purposely hiding suicide attempts and suicide ideation by coding them under false categories, such as “depression” and “no drug effect” (cf pp 3 and 4 of Part IV). Eli Lilly employee Claude Bouchy expressed shame about going along with this fraudulent practice: “I do not think I could explain to the BGA [the German regulatory agency], to a judge, to a reporter or even to my family why we would do this especially on the sensitive issue of suicide and suicide ideation."